Calculating Serious Infection Risk in IMID Patients Predictive modeling of data derived from the DANBIO registry (of treated IMID patients) revealed a 4 fold increased risk of serious infection in those starting biologic DMARD treatment. Read more: https://t.co/i2GwiCvCx6 https://t.co/9sZ79LyZ7u